Prof Ananya💙 @achoud72.bsky.social
@achoud72
NHS consultant no private work. Equality, liberty and justice, Chair in Clinical Oncology, Christie & University of Manchester, EIC BMJ Oncology. Own views
📣 Elucidating the mechanisms of lifestyle interventions in mitigating radiotherapy adverse effects: a scoping review Read the new review from @AmyHarwood91 @achoud72 and colleagues in BMJ Oncology now:
Join us for the 10th Jubilee Edition of #BLADDR25! Register now: tinyurl.com/bdf4fw7y ➡️Get insights on the latest #BladderCancer data translated into clinical practice by @achoud72, @DrFelixGuerrero and many more!
Ready to advance your oncology research at our Clinical Oncology Academic Day? Discover cutting-edge research, explore varied research pathways and discuss your ideas with leaders in the field. Book now: tinyurl.com/5n6haazw @achoud72 @onctrainees @teambeamNCCC
The team has a new (slightly overdue 🙃) MR Linac Blog! Check out 👀 what they’ve been up to! christie.nhs.uk/your-treatment…
INVITATION: Join us for the 2025 edition of the Global forum on GU Oncology! Register here👉 tinyurl.com/bdf4fw7y 3⃣ Meetings covering 3 disease areas: Renal, Bladder and Prostate Cancer 👥 Clinical case-based 🔁 Interactive sessions with voting and Q&A 🌐 International,…
✨ JUST OUT in EUO, New paper challenging a dogma. ⏩ MUST READ: @ConstanceHuck has done a great job to show that CIS is not always a contra-indication for Trimodal Therapy in the management of MIBC. 🙏Thanks to all co-authors for their input! sciencedirect.com/science/articl…
Patients receiving single agent adjuvant trastuzumab for early HER2 positive breast cancer at low risk of recurrence could receive 6 months rather than 12 months treatment. bmjoncology.bmj.com/content/4/1/e0…
You made it! You deserve it - easy nomination to write! Congratulations! @UoM_DCS @MCRCnews @RT_physics
I'm truly honored to receive the Doctoral Academy’s Best Contribution to PGR Environment Award. A heartfelt thank you to Professor Ananya Choudhury for the kind nomination and continued support. @achoud72 linkedin.com/posts/biolatti…
We are proud to launch the IBCN Exchange Grant, supporting early-career researchers in bladder cancer through international, short-term, research exchanges within the IBCN community. For more info and details or to become an IBCN member please visit: ibcnweb.com
After 39 years @MassGenBrigham and now his last day in clinic, wishing a happy retirement to my very dear one-of-a-kind colleague Dr. Anthony Zietman! Like a finely tuned proton, he has brought positive energy to everything-- from clinic to journal pages, to society leadership…
Although patient-reported outcomes are collected in many thousands of patients with cancer each year, these data are often not reported or methodological issues such as missing data hamper interpretation. We need to get this right, it matters. bmjoncology.bmj.com/content/4/1/e0…
Thanks so much @VedangMurthy for putting together the first ever #APCCC #SouthAsia and for including #SriLanka. It was great to meet so many colleagues from #SouthAsia #Prostatecancer #oncology @Vimukthini @YasiruMalinda @docpriyamvada
Finally Managed to gather a fantastic bunch of KOLs from India 🇮🇳 Bangladesh Sri Lanka and Nepal. Discussed the nuances of PCa Mx. Plenty of friendly banter and leg pulling. Official APCCC South Asia. Paper with similarities yet differences from @APCCC_Lugano coming soon.
Fantastic opportunity to network with experts in bladder cancer👀👇🏽
The International Bladder Cancer Group (IBCG) is pleased to announce the #IBCG2025 Travel Award, designed to support outstanding fellows and early-career academic faculty who are committed to advancing the field of bladder cancer. For more information and to apply:…
In PEACE-3 (EORTC 1333), the addition of 6 cycles of Ra223 to enzalutamide improves PSA response time and rates (≥90%), ALP reduction time (≥30%), and ALP normalization at 6 and 12 months. @EORTC @Silke_Gillessen @SoaresAndrey @GETUG_Unicancer @cancertrials_ie @sogug1
A 3-year structured exercise program initiated soon after adjuvant chemotherapy for colon cancer resulted in significantly longer disease-free survival. nejm.org/doi/full/10.10…
🚨May is Bladder Cancer awareness month🚨 What better way to recognise this than a Simply Oncology episode with the irrepressible @AlisonBirtle 🎙️We discuss peri-operative treatment and the NIAGRA trial 🎙️There is so much happening in #BladderCancer @TapiaJC1 @Actionbladderca
News for UK radiotherapy community. Pleased to say that thanks to @macmillancancer we have been able to establish #ctrad. We plan a proposals guidance meeting on 8.7.25 If you have a new trial idea, wish to attend please contact [email protected] to register. @RCRadiologists
Surgical discussions on Day 2 of our 12th Scottish Bladder Cancer Symposium at @RCSEd begin with Prof @UroDocAsh covering lymphadenectomy in radical cystectomy for #BladderCancer. @AlisonBirtle @achoud72 @LDyrskjot @BladderCancerUK
@ParamMariappan highlighting the importance of #turbt and AI -attention to detail and infrastructure to get the best outcome from the start in #bladdercancer #bcam #12thscottishbladdercancersymposium @RCSEd @UroDocAsh @achoud72 @BladderCancerUK #girft